rs121908825
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_017849.4(TMEM127):c.409+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_017849.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMEM127 | NM_017849.4 | c.409+1G>T | splice_donor_variant, intron_variant | Intron 3 of 3 | ENST00000258439.8 | NP_060319.1 | ||
| TMEM127 | NM_001193304.3 | c.409+1G>T | splice_donor_variant, intron_variant | Intron 3 of 3 | NP_001180233.1 | |||
| TMEM127 | NM_001407282.1 | c.157+1G>T | splice_donor_variant, intron_variant | Intron 2 of 2 | NP_001394211.1 | |||
| TMEM127 | NM_001407283.1 | c.157+1G>T | splice_donor_variant, intron_variant | Intron 2 of 2 | NP_001394212.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pheochromocytoma Pathogenic:3
- -
- -
The variant NM_017849.4:c.409+1G>T (chr2:96254832) in TMEM127 was detected in 1 heterozygote out of 58K WGS Icelanders (MAF= 0,001%). This variant has been reported in ClinVar previously as pathogenic. Based on ACMG criteria (PVS1, PM2, PP5) this variant classifies as likely pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.409+1G>T intronic pathogenic mutation results from a G to T substitution one nucleotide after coding exon 2 of the TMEM127 gene. This mutation was identified in a 38 year-old Spanish woman with a benign adrenal pheochromocytoma/paraganglioma whose tumor demonstrated loss of heterozygosity (LOH) of the wild-type allele. Subsequent RNA analysis confirmed that this alteration results in in-frame skipping of exon 3 (coding exon 2), which is a large percentage of the protein (Yao L et al. JAMA, 2010 Dec;304:2611-9). This nucleotide position is highly conserved in available vertebrate species. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at